07.06.2016
- Sun Pharma, India’s largest drugmaker, is selling two oral solid dosage manufacturing plants in the US, as well as 15 related (undisclosed) pharmaceutical products, to Frontida...
04.04.2016
- Indian generic drug maker Sun Pharma has agreed to buy a portfolio of brands from Novartis for $293 million. The Mumbai-based multi-national is acquiring 14 established...
15.02.2016
- On the rebound from its failed $27 billion hostile bid for Perrigo, Netherlands-domiciled, US-managed drugmaker Mylan has announced it will acquire Sweden’s Meda for 83.6 billion...
12.06.2013
- Pfizer said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent suit related to its acid-reflux drug. This is the first...
01.06.2013
- India's Sun Pharmaceutical Industries is in talks to buy Sweden's Meda for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with...
13.08.2012
- India's Sun Pharmaceutical Industries has upped the buy-out price for its Israeli unit Taro Pharma by 60%, winning over Taro's board and ending a long battle to gain full control...
12.04.2011
- U.S. drugmaker Merck & Co has formed a joint venture with India's Sun Pharmaceutical Industries Ltd to develop and manufacture branded generic drugs for emerging markets, the two...
